CVE-2026-21974

MEDIUM
2026-01-20 [email protected]
5.3
CVSS 3.1
Share

CVSS Vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Attack Vector
Network
Attack Complexity
Low
Privileges Required
None
User Interaction
None
Scope
Unchanged
Confidentiality
Low
Integrity
None
Availability
None

Lifecycle Timeline

2
Analysis Generated
Mar 12, 2026 - 21:54 vuln.today
CVE Published
Jan 20, 2026 - 22:16 nvd
MEDIUM 5.3

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Analysis

Unauthenticated attackers can read sensitive data from Oracle Life Sciences Central Designer 7.0.1.0 through an easily exploitable information disclosure vulnerability accessible via HTTP. The flaw requires no user interaction or privileges, allowing remote attackers with network access to gain unauthorized access to a subset of application data. …

Sign in for full analysis, threat intelligence, and remediation guidance.

Remediation

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Review data exposure and access controls.

Sign in for detailed remediation steps.

Priority Score

27
Low Medium High Critical
KEV: 0
EPSS: +0.0
CVSS: +26
POC: 0

Share

CVE-2026-21974 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy